CHIH


MSCI China Health Care ETF

Reasons to Consider CHIH

Targeted Exposure

CHIH is a targeted play on the Health Care Sector in China – the world’s second largest economy by GDP.

ETF Efficiency

In a single trade, CHIH delivers access to dozens of health care companies within the MSCI China Index, providing investors an efficient vehicle to express a sector view on China.

All Share Exposure

The Index incorporates all eligible securities as per MSCI’s Global Investable Market Index Methodology, including China A, B and H shares, Red chips, P chips and foreign listings, among others.

Key Information As of 10/27/21

Inception Date 12/07/18
Total Expense Ratio 0.65%
Net Assets $16.70 million
NAV $24.92
Fact Sheet

ETF Summary

The Global X MSCI China Health Care ETF (CHIH) seeks to invest in large- and mid-capitalization segments of the MSCI China Index that are classified in the Health Care Sector as per the Global Industry Classification System (GICS).

ETF Objective

The Global X MSCI China Health Care ETF (CHIH) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI China Health Care 10/50 Index.

Trading Details As of 10/27/21

Ticker CHIH
Bloomberg Index Ticker NU722071
CUSIP 37954Y541
ISIN US37954Y5419
Primary Exchange NYSE Arca
Shares Outstanding 670,002
Number of Holdings 92
30-Day Median Bid-Ask Spread 1.18%

Distributions As of 10/27/21

30-Day SEC Yield 0.15%
Distribution Frequency Semi-Annually

ETF Prices As of 10/27/21

NAV $24.92 Daily Change -$0.77 -2.99%
Market Price $24.74 Daily Change -$0.79 -3.09%

Performance History

As of recent month & quarter-end (09/30/21)
As of recent month & quarter-end (09/30/21)
Fund NAV Market Price Index
1 Year 12.96% 12.18% 13.75%
Since Inception 22.85% 22.90% 23.76%
1 Year 12.96% 12.18% 13.75%
Since Inception 22.85% 22.90% 23.76%
Year-to-Date -1.45% -0.34% -0.99%
1 Month 0.95% 1.18% 1.01%
3 Months -19.40% -19.12% -19.28%
Since Inception 78.47% 78.68% 82.27%
Year-to-Date -1.45% -0.34% -0.99%
1 Month 0.95% 1.18% 1.01%
3 Months -19.40% -19.12% -19.28%
Since Inception 78.47% 78.68% 82.27%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 10/27/21

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
9.83 2269 HK WUXI BIOLOGICS CAYMAN INC BL6B9P1 15.11 108,680 1,642,071.83
8.86 BGNE BEIGENE LTD-ADR BYYWPW6 367.27 4,027 1,478,996.29
5.32 1093 HK CSPC PHARMACEUTI 6191997 1.09 817,208 889,012.01
5.16 1801 HK INNOVENT BIOLOGICS INC BGR6KX5 8.96 96,200 861,590.39
4.37 ZLAB ZAI LAB LTD-ADR BD9GVY0 104.95 6,950 729,402.50
4.25 1177 HK SINO BIOPHARMACEUTICAL B00XSF9 0.74 958,400 709,862.02
3.90 2359 HK WUXI APPTEC CO LTD-H BGHH0L6 20.88 31,176 651,045.10
3.01 1548 HK GENSCRIPT BIOTECH CORP BD9Q2J2 4.23 118,700 502,170.59
2.97 241 HK ALIBABA HEALTH BRXVS60 1.33 373,300 495,384.42
2.50 1066 HK SHANDONG WEIG-H 6742340 1.71 244,300 417,182.61
2.18 300760 C2 SHENZHEN MINDR-A BHQK864 56.30 6,461 363,743.54
1.97 1099 HK SINOPHARM GROUP CO-H B3ZVDV0 2.39 137,400 328,627.82
1.91 603259 C1 WUXI APPTEC CO LTD-A BHWLWV4 21.20 15,024 318,541.74
1.83 853 HK MICROPORT SCIENTIFIC CORP B676TW7 4.75 64,200 305,038.13
1.81 600276 C1 JIANGSU HENGRU-A BP3R369 7.67 39,272 301,319.85
1.73 HCM HUTCHMED CHINA-ADR BYXV9H7 30.81 9,352 288,135.12
1.72 600436 C1 ZHANGZHOU PIEN-A BP3R7Z6 64.90 4,426 287,261.01
1.67 3692 HK HANSOH PHARMACEU BJYKB72 2.35 118,300 278,381.58
1.64 1833 HK PING AN HEALTHCA BDRYVB3 5.97 45,900 274,159.35
1.55 867 HK CHINA MEDICAL SY B6WY993 1.73 150,300 259,367.86
1.53 300015 C2 AIER EYE HSPTL-A BD5CLQ4 7.20 35,524 255,895.69
1.48 2196 HK FOSUN PHARMA-H B8XBQ96 4.72 52,400 247,287.41
1.40 3759 HK PHARMARON BEIJ-H BK72QD3 20.52 11,350 232,934.28
1.33 300122 C2 CHONGQING ZHIF-A BD5CJY8 22.96 9,633 221,159.09
1.24 3347 HK HANGZHOU TIGER-H BMZC7F8 18.99 10,920 207,399.54
1.12 6185 HK CANSINO BIOLOGICS INC-H BJKDJS2 27.44 6,800 186,598.43
1.10 1951 HK JINXIN FERTILITY BJ9JY53 1.57 117,700 184,343.74
1.07 2607 HK SHANGHAI PHARM-H B4Q4CJ6 1.84 97,400 179,101.68
1.02 570 HK TRAD CHI MED 6971779 0.47 359,100 169,929.15
0.97 IMAB I-MAB-SPONSORED ADR BKRRKY7 61.95 2,608 161,565.60
0.93 1530 HK 3SBIO INC BY9D3L9 0.94 166,200 155,798.47
0.87 000538 C2 YUNNAN BAIYAO-A BD5CP95 14.37 10,110 145,274.48
0.78 9926 HK AKESO INC BLFJ7Y1 5.69 23,000 130,871.71
0.69 300347 C2 HANGZHOU TIGER-A BD5CCK5 25.01 4,616 115,447.83
0.67 600196 C1 SHANGHAI FOSUN-A BP3R3M5 7.78 14,274 111,014.92
0.67 3320 HK CHINA RESOURCES BYNGG26 0.48 229,500 110,962.23
0.64 000661 C2 CHANGCHUN HIGH-A BD5CDB3 42.24 2,528 106,771.30
0.62 2005 HK SSY GROUP LTD BYP9J68 0.48 213,500 102,677.23
0.59 000963 C2 HUADONG MEDICINE CO LTD-A BD5CM94 5.28 18,711 98,849.35
0.57 300142 C2 WALVAX BIOTECHNOLOGY CO-A BD5CG36 8.94 10,700 95,668.54
0.56 002821 C2 ASYMCHEM LABOR-A BD6V5C4 61.32 1,513 92,770.23
0.53 300896 C2 IMEIK TECHNOLO-A BNR4MY3 97.73 900 87,959.78
0.52 300759 C2 PHARMARON BEIJ-A BK4XYC4 27.75 3,100 86,026.13
0.49 600763 C1 TOPCHOICE MEDI-A BYYFJH8 37.57 2,180 81,896.39
0.49 300601 C2 SHENZHEN KANGT-A BFY8HT2 17.84 4,543 81,067.27
0.46 002001 C2 ZHEJIANG NHU CO LTD-A BD5CH66 4.22 18,240 76,991.88
0.45 2500 HK VENUS MEDTECH -H BL6V047 4.46 17,000 75,854.80
0.45 600332 C1 GUANGZHOU BAIY-A BP3R4Q6 4.55 16,559 75,412.38
0.41 603392 C1 BEIJING WANTAI-A BMXTWX4 35.62 1,900 67,678.11
0.34 002007 C2 HUALAN BIOLOGI-A BD5CL19 4.37 13,070 57,131.36
0.32 300595 C2 OVCTEK CHINA INC-A BHQPSJ2 10.74 5,024 53,978.84
0.31 600998 C1 JOINTOWN PHARMACEUTICAL-A BP3R541 2.21 23,370 51,534.14
0.31 002044 C2 MEINIAN ONEHEA-A BD73L10 1.12 45,920 51,348.19
0.30 300003 C2 LEPU MEDICAL TECHNOLOGY-A BD5CM16 3.92 12,901 50,521.34
0.30 002294 C2 SHENZHEN SALUBRIS PHARM-A BD5CM05 4.47 11,200 50,008.21
0.29 000423 C2 DONG-E-E-JIAOCO LTD-A BD5CM61 6.25 7,800 48,745.81
0.29 BNR BURNING ROCK-ADR BMBKH34 14.28 3,395 48,480.60
0.28 603882 C1 GUANGZHOU KING-A BFYX689 17.07 2,700 46,094.01
0.28 002422 C2 SICHUAN KELUN-A BD5CL08 2.71 17,000 45,995.17
0.26 600867 C1 TONGHUA DONGBA-A BP3R808 1.68 25,305 42,543.38
0.25 300529 C2 JAFRON BIOMEDI-A BFY8H03 7.94 5,200 41,312.76
0.24 603858 C1 SHANDONG BUCHA-A BYW5NC3 2.77 14,487 40,056.95
0.23 600161 C1 BEIJING TIAN-A BP3R9J4 4.52 8,400 37,965.95
0.22 601607 C1 SHANG PHARM -A BP3R4Z5 2.88 12,600 36,317.26
0.20 002223 C2 JIANGSU YUYUE-A BD5CJM6 5.56 6,100 33,885.97
0.20 603707 C1 NANJING KING-F-A BF2DZL7 5.48 6,136 33,654.12
0.19 603127 C1 JOINN LABORATO-A BK94819 22.96 1,400 32,141.88
0.19 300676 C2 BGI GENOMICS CO LTD-A BFY8H58 13.12 2,433 31,912.88
0.19 300558 C2 BETTA PHARMACE-A BD6QWL7 13.01 2,420 31,488.78
0.19 000739 C2 APELOA PHARMA-A BD5LY17 5.10 6,100 31,119.38
0.18 002603 C2 SHIJIAZHUANG Y-A BD5CHJ9 2.47 12,027 29,662.39
0.18 600079 C1 HUMANWELL HEAL-A BP3R712 3.19 9,200 29,366.22
0.17 603456 C1 ZHEJIANG JIUZH-A BMQBVL8 7.85 3,700 29,048.43
0.17 002252 C2 SHANGHAI RAAS -A BD5CPJ5 0.99 28,800 28,601.14
0.16 600521 C1 ZHEJIANG HUAHA-A BP3RBR6 2.83 9,510 26,905.20
0.16 300357 C2 ZHEJIANG WOLWO-A BFY8GY0 8.28 3,223 26,684.64
0.16 300253 C2 WINNING HEALTH-A BD5CKZ6 1.95 13,470 26,311.60
0.14 300677 C2 INTCO MEDICAL-A BMTCVT6 8.43 2,850 24,037.68
0.14 000999 C2 CHINA RESOURCE-A BD5CL42 3.94 6,000 23,637.23
0.13 002030 C2 DAAN GENE CO LTD-A BD5CKW3 2.93 7,560 22,156.88
0.13 002019 C2 YIFAN PHARMACE-A BD5CDK2 2.54 8,400 21,360.78
0.12 603658 C1 AUTOBIO DIAGNO-A BYW5N89 8.80 2,282 20,085.70
0.12 688185 C1 CANSINO BIOLOGICS INC-A BMD9JD3 45.91 417 19,143.46
0.11 600511 C1 CHINA NATIONAL-A BP3R9B6 4.77 4,000 19,061.17
0.11 000513 C2 LIVZON PHARM-A BD5CQ25 5.48 3,400 18,642.67
0.11 CASH 1.00 18,485 18,396.94
0.11 600380 C1 JOINCARE PHARM-A BP3RBV0 1.75 10,100 17,706.97
0.10 000623 C2 JILIN AODONG P-A BD5CLG4 2.49 6,700 16,671.02
0.09 002399 C2 SHENZHEN HEPAL-A BD5CKT0 2.32 6,700 15,518.40
0.09 600529 C1 SHANDONG PHAR-A BMVB2W1 4.85 3,200 15,509.18
0.08 300463 C2 MACCURA BIOTECH CO LTD-A BD5M283 4.42 3,000 13,249.61
0.08 300482 C2 GUANGZHOU WOND-A BFY8GZ1 5.31 2,390 12,689.80
0.00 MICROPORT SCIENTIFIC RTS 0.00 58 0.00
Holdings are subject to change.

ETF Characteristics As of 10/27/21

Return on Equity 9.50%
Weighted Avg. Market Cap 11,086 M
2020 2021
Price-to-earnings 60.67 40.27
Price-to-book value 3.96 3.73

Source: AltaVista Research, LLC

ETF Risk Stats As of 10/27/21

Versus Beta
S&P 500 0.52
MSCI EAFE 0.49
MSCI Emg. Mkts 0.77
Standard Deviation 25.60%

Source: AltaVista Research, LLC

ETF Research

View More Related Research

Investing involves risk, including the possible loss of principal. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles, or from economic or political instability in other nations. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Securities focusing on a single country and narrowly focused investments may be subject to higher volatility. CHIH is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by MSCI, nor does MSCI make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with MSCI.